Newsroom

Blog

Taking the STING out of Oncology

For many tumor indications optimal treatment selection often depends on the presence of specific tumor biomarkers such as PDL1.

Read More
Written By:
Kirsteen Maclean

EGFR: Master Regulator of the Oncology Universe

Epidermal growth factor receptor (EGFR), also referred to as ERBB1 or HER1 is part of a broader ERBB family of receptor tyrosine kinases and plays a crucial role in the regulation of cell growth, s

Read More
Written By:
Kirsteen Maclean

AACR 2024: Spatial Biology, part-2

Spatial biology is an ever-evolving discipline focusing on improving our understanding of biological processes within the context of spatial organization, such as how cells are arranged within tiss

Read More
Written By:
Kirsteen Maclean

AACR 2024: Drug Targets, part-1

Margaret Foti, PhD, MD, chief executive officer of the American Association for Cancer Research (AACR), kicked off this year’s opening ceremony celebrating an outstanding year for the organization.

Read More
Written By:
Kirsteen Maclean

Randomized Controlled Trials (RCTs) and Real-world Outcomes in Hematological Malignancies: Minding the Gap

A blog by Jeff Elton, PhD | CEO, ConcertAI and Lindsey Gasparini | VP, Informatics at NeoGenomics
Read More

SITC Overview 2023

Following from last year’s record year of attendance held in Boston, this year’s 38th annual Society for Immunotherapy of Cancer (SITC) meeting held in sunny San Diego proved just as popular attrac

Read More
Written By:
Kirsteen Maclean

NeoGenomics highlighting advances in drug development strategies at recent clinical meetings

NeoGenomics is pleased to have attended meetings this year where we've had the opportunity to highlight advances in drug development strategies.

Read More

Women's Health and Fitness Day

September 27 is National Women's Health And Fitness Day. This annual observance strives to spread education about health and wellness, encourage women to prioritize their health, and more.

Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients